Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Giant Med-Pharma Service Group is a China-based contract research organization focused on pharmaceutical, medical device, and broader healthcare product development services. The group appears to operate primarily through Beijing Jingchengtong Medicine Technology and related affiliates, offering clinical CRO and SMO services, regulatory registration support, data management and biostatistics, medical writing, pharmacovigilance, market access, and medical information services. Publicly available descriptions indicate the company serves both multinational and domestic drug developers and has built a nationwide service footprint in China, with additional international liaison offices. Rather than developing a proprietary therapeutic pipeline, the company functions as a service provider supporting clinical development and commercialization activities for clients. Its positioning is that of an established Chinese outsourced development partner with more than a decade of operating history in innovative drug R&D services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giant Med-Pharma Service Group.